BUSINESS

• Lilly Warns Against Off-Label Use of Mounjaro
  June 11, 2026

• BMS Seeks Japan Approval for Mezigdomide in Multiple Myeloma
  June 11, 2026

• SanBio Sees Akuugo Expanding to 20-30 Treatment Centers
  June 11, 2026

• Rakuten Medical to Promote President Maeda to CEO
  June 11, 2026

• Metagen Starts Global PI/II Trial of Oral FMT Therapy
  June 11, 2026

• Sumitomo Completes Enrollment for Enzomenib PII Analysis
  June 11, 2026

• Takeda's Entyvio IV Under FDA Review for Pediatric Use
  June 11, 2026

• Japan’s First OTC ED Drug Cialis to Hit Shelves in August
  June 11, 2026

• Healios Countersues AND Medical over Unpaid Milestone
  June 10, 2026

• Moderna Japan Looks Beyond COVID for Next Growth Pillars
  June 9, 2026

• Oncolys Targets 300 Hospitals for Telomelysin Rollout
  June 9, 2026

• CSL Behring Japan President Yoshida to Step Down
  June 8, 2026

• Japan Approves Oncolys’ Telomelysin for Esophageal Cancer
  June 8, 2026

• Takeda Swings to Loss after Booking Amitiza Litigation Charge
  June 8, 2026

• GNI to Acquire Ayumi Pharma in 44.8 Billion Yen Deal
  June 8, 2026

• Shionogi Releases Japan’s First Therapy App for Pediatric ADHD
  June 8, 2026

• Kaken Files Head Lice Treatment in Japan
  June 8, 2026

• UCB Japan Seeks Pediatric Use, Dry Syrup Approval for Briviact
  June 8, 2026

• Nobelpharma’s Nobelzin Makes China Debut for Wilson Disease
  June 8, 2026

• Japan Ethical Drug Sales Rise 7.3% in April: Crecon
  June 8, 2026

ページ

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »